Sie suchten nach: morbid (Englisch - Maltesisch)

morbid thoughts
Ħsibijiet morbużi

initial insomnia morbid thoughts
insonnja inizjali Ħsibijiet morbużi

ireland: morbid anatomy and histopathology
l-irlanda: morbid anatomy and histopathology

presence of morbid anatomical lesions in fish
presenza ta’ feriti anatomiċi morbużi fil-ħut

united kingdom: morbid anatomy and histopathology;
ir-renju unit: morbid anatomy and histopathology;

in addition, these conditions may be co-morbid with major depressive disorder.
barra minn hekk dawn il-kundizzjonijiet jistgħu jkunu preżenti bħala marda oħra flimkien mad-disturb tad-depressjoni maġġuri.

many of these cases involved patients with co-morbid conditions including swallowing disorders or oesophageal abnormalities.
Ħafna minn dawn il-każijiet kienu jinvolvu pazjenti b’kundizzjonijiet komorbidi li jinkludu diffikultajiet biex wieħed jibla’ jew anormalitajiet oesofagali.

cancer, co morbid conditions (e.g. anaemia, coagulopathies, infection), smoking.
kanċer, kundizzjonijiet li fl-istess waqt idgħajfu lill-pazjent (eż. anemija, mard tal- koagulazzjoni, infezzjoni), it-tipjip.

cancer, co-morbid conditions (e.g. anaemia, coagulopathies, infection), smoking
kanċer, kondizzjonijiet ko-morbużi (eż. anemija, disturbi fit-tagħqid tad-demm, infezzjoni), tipjip

cancer, co-morbid conditions (e.g. anaemia, coagulopathies, infection), smoking.
kanċer, kundizzjonijiet komorbidi (eż. anemija, koagulopatiji, infezzjoni), tipjip.

caution should be exercised when considering the use of sugammadex in patients receiving therapeutic anticoagulation for a pre-existing or co- morbid condition.
għandu jkun hemm kawtela meta jiġi kkunsidrat l-użu ta’ sugammadex f’pazjenti li jkunu qed jirċievu anti-kogualzzjoni terapewtika għal kundizzjoni li tkun teżisti minn qabel jew li hi ko-morbida.

as there are many co-morbid conditions that may affect laboratory values in sjia, the decision to discontinue tocilizumab for a laboratory abnormality should be based upon the medical assessment of the individual patient.
peress li hemm ħafna kundizzjonijiet ko-morbidi li jistgħu jaffettwaw il-valuri tal-laboratorju f’sjia, id-deċiżjoni biex jitwaqqaf tocilizumab minħabba anormalitajiet tal-laboratorju għandha tkun ibbażata fuq il- valutazzjoni medika tal-pazjent individwali.

in patients with co-morbid major depressive disorder, the starting and maintenance dose is 60 mg once daily (please see also dosing recommendation above).
f’pazjenti li fl-istess ħin qed ibatu wkoll minn disturb depressiv maġġuri, id-doża inizjali u ta’ manteniment hi ta’ 60 mg darba kuljum (jekk jogħġbok ara wkoll ir-rakkomandazzjoni tad-dożaġġ fuq).

overall of 225 patients for whom giant cell tumours of bone surgery (excluding lung metastases only) was planned, 109 had no surgery performed and 84 underwent a less morbid procedure than planned at baseline.
b’mod globali minn 225 pazjent li kellhom ippjanata kirurġija ta’ tumuri taċ-ċelluli ġganti tal-għadam (eskluż metastasi fil-pulmun biss), 109 ma kellhom l- ebda kirurġija u 84 għaddew minn proċedura inqas morbida milli kien ippjanat fil-linja bażi.

the most serious events often occurred in patients exposed to other medicinal products or substances known to be associated with hepatotoxicity or in the presence of co-morbid medical conditions (e.g. metastasising malignant disease, severe infection and sepsis, alcohol abuse).
l-aktar każijiet serji, ħafna drabi seħħew f’pazjenti li ġew esposti għal prodotti mediċinali oħrajn jew sustanzi magħrufa li huma assoċjati ma’ epatotossicità jew fil-preżenża ta’ żewġ kundizzjonijiet mediċi indipendenti minn xulxin (eż. mard malinn b’metastasi, infezzjoni qawwija u sepsis, abbuż ta’ l-alkoħol).